- Direction
- Unknown
- Own history
- —
- Peers
- 77th
- Persistence
- TRANSIENT
· Pharmaceutical Preparations
RESEARCH SNAPSHOTKiniksa Pharmaceuticals International, plc's latest supported as-filed period reports revenue of $286.0M, 58.1% above the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Separate current dimensions—not a universal score or investment ranking.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.06% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 16.63% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 58.12% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 37.78% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 90.29% · CORE
Level · gp.fundamentals.operating_margin
Raw value 18.97% · CORE
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Inventory increased 161.0%; Inventory / revenue moved 1489 bp higher.
2 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 58.1%; Operating margin moved 568 bp higher; Operating income increased 125.8%.
3 evidence-backed componentsInventory changed +161.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
KNSA · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001104659-26-119186SEC ↗8-KOct 27, 2026Period Oct 27, 20260001730430-26-000037SEC ↗8-KOct 22, 2026Period Oct 17, 20260001730430-26-000034SEC ↗4Sep 3, 2026Period Sep 1, 20260001835458-26-000012SEC ↗4Sep 3, 2026Period Sep 1, 20260001532218-26-000016SEC ↗4Sep 3, 2026Period Sep 1, 20260001532218-26-000014SEC ↗4Sep 3, 2026Period Sep 1, 20260001741533-26-000010SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Sep 1, 2026Filed Sep 3, 2026 | Moat RossCHIEF OPERATING OFFICER | Option ExerciseDirect | 2,477 | — | — | Form 4 ↗ |
| Sep 1, 2026Filed Sep 3, 2026 | Moat RossCHIEF OPERATING OFFICER | Option ExerciseDirect | 1,611 | — | — | Form 4 ↗ |
| Sep 1, 2026Filed Sep 3, 2026 | Moat RossCHIEF OPERATING OFFICER | Option ExerciseDirect | 1,740 | — | — | Form 4 ↗ |
| Sep 1, 2026Filed Sep 3, 2026 | Moat RossCHIEF OPERATING OFFICER | Option ExerciseDirect | 2,457 | — | — | Form 4 ↗ |
| Sep 1, 2026Filed Sep 3, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 11.46% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 4.57% · OPTIONAL
Total assets changed +38.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed +43.5% from the comparable as-filed period.
Operating income changed +125.8% from the comparable as-filed period.
Revenue changed +58.1% from the comparable as-filed period.
Operating cash flow changed +41.2% from the comparable as-filed period.
Operating margin changed +568 basis points from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-09-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001857177-26-000008| Moat RossCHIEF OPERATING OFFICER |
| Tax WithholdingDirect |
| 4,007 |
| $79 |
| $317,675 |
| Form 4 ↗ |
| Sep 1, 2026Filed Sep 3, 2026 | Moat RossCHIEF OPERATING OFFICER | Grant Or AwardDirect | 9,250 | $0 | $0 | Form 4 ↗ |
| Sep 1, 2026Filed Sep 3, 2026 | Moat RossCHIEF OPERATING OFFICER | Grant Or AwardDirect | 36,950 | $0 | $0 | Form 4 ↗ |
| Sep 1, 2026Filed Sep 3, 2026 | Moat RossCHIEF OPERATING OFFICER | Option ExerciseDirect | 2,457 | $0 | $0 | Form 4 ↗ |
| Sep 1, 2026Filed Sep 3, 2026 | Moat RossCHIEF OPERATING OFFICER | Option ExerciseDirect | 1,740 | $0 | $0 | Form 4 ↗ |
| Sep 1, 2026Filed Sep 3, 2026 | Moat RossCHIEF OPERATING OFFICER | Option ExerciseDirect | 1,611 | $0 | $0 | Form 4 ↗ |
| Sep 1, 2026Filed Sep 3, 2026 | Moat RossCHIEF OPERATING OFFICER | Option ExerciseDirect | 2,477 | $0 | $0 | Form 4 ↗ |
| Sep 1, 2026Filed Sep 3, 2026 | Patel Sanj KCHAIRMAN & CEO | Option ExerciseIndirect | 9,991 | — | — | Form 4 ↗ |
| Sep 1, 2026Filed Sep 3, 2026 | Patel Sanj KCHAIRMAN & CEO | Option ExerciseIndirect | 6,481 | — | — | Form 4 ↗ |
| Sep 1, 2026Filed Sep 3, 2026 | Patel Sanj KCHAIRMAN & CEO | Option ExerciseIndirect | 6,237 | — | — | Form 4 ↗ |
| Sep 1, 2026Filed Sep 3, 2026 | Patel Sanj KCHAIRMAN & CEO | Option ExerciseIndirect | 8,609 | — | — | Form 4 ↗ |
| Sep 1, 2026Filed Sep 3, 2026 | Patel Sanj KCHAIRMAN & CEO | Tax WithholdingIndirect | 15,144 | $79 | $1.2M | Form 4 ↗ |
| Sep 1, 2026Filed Sep 3, 2026 | Patel Sanj KCHAIRMAN & CEO | Grant Or AwardDirect | 30,050 | $0 | $0 | Form 4 ↗ |
| Sep 1, 2026Filed Sep 3, 2026 | Patel Sanj KCHAIRMAN & CEO | Grant Or AwardDirect | 120,150 | $0 | $0 | Form 4 ↗ |
| Sep 1, 2026Filed Sep 3, 2026 | Patel Sanj KCHAIRMAN & CEO | Option ExerciseDirect | 8,609 | $0 | $0 | Form 4 ↗ |
| Sep 1, 2026Filed Sep 3, 2026 | Patel Sanj KCHAIRMAN & CEO | Option ExerciseDirect | 6,237 | $0 | $0 | Form 4 ↗ |